Filter
382
Text search:
Artemisinin
Featured
Recommendations
29
New Publications
189
Language
Document type
No document type
276
Studies & Reports
48
Guidelines
33
Strategic & Response Plan
9
Fact sheets
7
Manuals
6
Situation Updates
2
Training Material
1
Countries / Regions
Liberia
21
Kenya
21
Uganda
19
Sierra Leone
18
Myanmar / Burma
14
Nigeria
13
Tanzania
13
Rwanda
13
Malawi
13
Senegal
12
Ghana
12
Ethiopia
10
India
10
Zambia
9
Global
9
Zimbabwe
8
Cameroon
7
Cambodia
7
Indonesia
7
Madagascar
7
Africa
7
Nepal
6
South Africa
6
Bangladesh
6
Burkina Faso
4
Congo, Democratic Republic of
4
Mozambique
4
Benin
4
Guinea
3
South–East Asia Region
3
Mali
2
Philippines
2
Somalia
2
Thailand
2
Namibia
2
Botswana
2
Vietnam
2
Haiti
1
Lebanon
1
Papua New Guinea
1
Sudan
1
Eswatini/ Swaziland
1
North Macedonia
1
East and Southern Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Latin America and the Carribbean
1
Western and Central Europe
1
Paraguay
1
Asia
1
Venezuela
1
Laos
1
Turkmenistan
1
Authors & Publishers
Publication Years
Category
Countries
262
Clinical Guidelines
41
Public Health
25
Women & Child Health
9
Pharmacy & Technologies
7
Capacity Building
5
Key Resources
2
Toolboxes
AMR
17
Pharmacy
17
Global Health Education
5
Health Financing Toolbox
5
Ebola
4
HIV
4
Caregiver
4
NTDs
4
COVID-19
3
TB
2
Planetary Health
2
NCDs
2
Conflict
1
Rapid Response
1
Health Financing
1
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of disease spread, severe illness and death.1 AMR in recent years has
...
The 2018 NDHS is a national sample survey that provides up-to-date information on demographic and health indicators. The sample was selected using a stratified, two-stage cluster design, with enumeration areas (EAs) as the sampling units for the first stage. The second stage was a complete listing o
...
The brief concludes that sustaining the continuity of EHS requires policies that ensure a whole-society and systems strengthening approach. This involves increased health care investment, community engagement, disease control regulations, and multisector approaches to improve resilience, EHS quality
...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t
...
Sector Environmental Guidelines, Full technical Update
PLoS Neglected Tropical diseases August 16, 2021 https://doi.org/10.1371/journal.pntd.0009697
Chagas disease, also known as American trypanosomiasis, is a neglected tropical disease transmitted by triatomine insects, first identified in 1909. Chagas disease affects approximately 6–7 million peop
...
Front Chem. 2021; 9: 622286.
Published online 2021 Mar 12. doi: 10.3389/fchem.2021.622286
PLoS Negl Trop Dis 15(8): e0009697. Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses t
...
The publication of the of the Antimicrobial Treatment Guidelines represents the
culmination of the efforts of the Antimicrobial Stewardship Program of ICMR to publish treatment guidelines for common syndromes in India. These guidelines are targeted for the health care settings. It aims to rationali
...
Financing Global Health 2016: Development Assistance, Public and Private Health Spending for the Pursuit of Universal Health Coverage presents a complete analysis of the resources available for health in 184 countries, with a particular focus on development assistance for health (DAH). DAH was estim
...
I examine the effectiveness of donors in targeting the highest burden of malaria in the Democratic Republic of Congo when health information structure is fragmented. I exploit local variations in the burden of malaria induced by mining activities as well as financial and epidemiological data from he
...
Ending the epidemics of HIV, tuberculosis and malaria by 2030 is within reach, but not yet fully in our grasp.
With only 11 years left, we have no time to waste. We must step up the fight now.
Strengthening resource tracking and monitorig health expanditure
Financing Global Health 2015 is the seventh edition of IHME’s annual series on global health financing. This report captures trends in development assistance for health (DAH) and government health expenditure as source (GHE-S) in low- and middle-income countries. Annually updated GHE-S and DAH est
...
While there has been real progress in addressing the burden of disease in the WHO African region, the COVID-19 pandemic has highlighted the link between health, economics and security, as the region saw decades of progress threatened, including positive trends in decreasing inequality. In the Africa
...
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of
...
Prompt, effective antimalarial treatment, and supportive care can substantially reduce the rate of mortality from severe malaria. However, many children in malaria-endemic countries do not have access to health facilities or a qualified health care provider and do not receive the necessary care in a
...
In 2019, the Global Fund’s 6th Replenishment raised more than $USD14 billion to fight HIV, Tuberculosis and Malaria. Just two years later, the world has changed significantly. Put simply: COVID-19 devastated prevention and treatment programs. For the first time since the Global Fund’s founding,
...
Ahead of World Malaria Day, the WHO Global Malaria Programme published a new operational strategy outlining its priorities and key activities up to 2030 to help change the trajectory of malaria trends, with a view to achieving the global malaria targets. The strategy outlines 4 strategic objectives
...
